Why Tandem Diabetes Care Inc (TNDM) Stock Is Rising
As of 2026-07-20, Tandem Diabetes Care Inc (TNDM) has a next-year EPS growth estimate of 119.84%. Featured in our EPS revision report on 2026-07-20.
Why TNDM Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Tandem Diabetes Care Inc's next-year EPS growth estimate from 113.09% to 119.85% on 2026-07-16.
- ·Current-Year Growth: Projected at 53.47%, supporting the forward estimate revision.
News Context
The primary structural driver for TNDM's rise is the July 16 analysts' upgrade, boosting next-year EPS growth estimates by 6.76 percentage points. This revision likely reflects momentum from the company's Q1 2026 earnings beat and the announced plan to file a tubeless insulin pump with the FDA this quarter, a key product catalyst. The upward trend has continued as the upgraded growth estimate (now 119.84%) sustains investor optimism.
Generated 2026-07-20 · news as of 2026-07-20
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 119.84%
- EPS growth this year
- 53.47%
- EPS next quarter (est)
- -$0.32
- Last price
- $18.10
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-20 | 119.84% | 53.47% | -$0.32 | $18.10 |
| 2026-07-19 | 119.84% | 53.47% | -$0.32 | $17.08 |
| 2026-07-17 | 119.84% | 53.47% | -$0.32 | $17.08 |
| 2026-07-16 | 119.85% | 53.47% | -$0.32 | $16.29 |
| 2026-07-15 | 113.09% | 52.09% | -$0.33 | $15.28 |
| 2026-07-14 | 113.09% | 52.09% | -$0.33 | $15.54 |
| 2026-07-13 | 113.79% | 52.29% | -$0.33 | $16.25 |
| 2026-07-12 | 114.35% | 52.47% | -$0.33 | $15.41 |
| 2026-07-09 | 114.35% | 52.47% | -$0.33 | $15.37 |
| 2026-07-08 | 114.35% | 52.47% | -$0.33 | $15.16 |
| 2026-07-07 | 114.35% | 52.47% | -$0.33 | $15.43 |
| 2026-07-06 | 114.35% | 52.47% | -$0.33 | $15.42 |
| 2026-07-05 | 114.35% | 52.47% | -$0.33 | $15.32 |
| 2026-07-02 | 112.46% | 52.58% | -$0.33 | $15.32 |
| 2026-07-01 | 112.46% | 52.58% | -$0.33 | $15.75 |
| 2026-06-30 | 112.46% | 52.58% | -$0.33 | $15.09 |
| 2026-06-29 | 112.46% | 52.58% | -$0.33 | $15.83 |
| 2026-06-28 | 112.46% | 52.58% | -$0.33 | $16.24 |
| 2026-06-25 | 112.46% | 52.58% | -$0.33 | $15.76 |
| 2026-06-24 | 112.46% | 52.58% | -$0.33 | $15.02 |
| 2026-06-23 | 112.46% | 52.58% | -$0.33 | $14.41 |
| 2026-06-22 | 111.62% | 52.18% | -$0.33 | $14.34 |
| 2026-06-21 | 111.62% | 52.18% | -$0.33 | $15.30 |
| 2026-06-18 | 109.98% | 52.65% | -$0.33 | $15.30 |
| 2026-06-17 | 109.98% | 52.65% | -$0.33 | $15.40 |
| 2026-06-16 | 109.98% | 52.65% | -$0.33 | $16.69 |
| 2026-06-15 | 109.98% | 52.65% | -$0.33 | $16.76 |
| 2026-06-14 | 109.98% | 52.65% | -$0.33 | $16.60 |
| 2026-06-11 | 109.98% | 52.65% | -$0.33 | $15.80 |
| 2026-06-10 | 109.98% | 52.65% | -$0.33 | $16.23 |
Reports Featuring TNDM
Recent News
Screen Performance
Aggregate stats across all 1871 tickers our top-EPS-revision screen has flagged over the past 110 days.
- Median return since detection
- +2.1%
- % of tickers in the green
- 55%
- Median return on winners
- +20.4%
- Large revisions captured
- 1057
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Tandem Diabetes Care Inc (TNDM) stock go up recently?▾
Tandem Diabetes Care Inc (TNDM) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 113.09% to 119.85% on 2026-07-16. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Tandem Diabetes Care Inc's next-year EPS growth estimate?▾
As of 2026-07-20, Tandem Diabetes Care Inc (TNDM) has a next-year EPS growth estimate of 119.84%, based on analyst consensus.
When was the latest EPS estimate revision for TNDM?▾
The most recent revision occurred on 2026-07-17, when analysts adjusted the next-year EPS growth estimate from 119.85% to 119.84%.
What sector and industry does Tandem Diabetes Care Inc belong to?▾
Tandem Diabetes Care Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TNDM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Tandem Diabetes Care Inc (TNDM) appears here because it was detected by our daily top-EPS-revision-performer screen.